Atherosclerosis
Volume 221, Issue 1 , Pages 91-97, March 2012

Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL

  • Sara Elsøe

      Affiliations

    • Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Denmark
    • Contributed equally.
  • ,
  • Josefin Ahnström

      Affiliations

    • Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, University Hospital, Malmö, Sweden
    • Contributed equally.
  • ,
  • Christina Christoffersen

      Affiliations

    • Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Denmark
  • ,
  • Andrew N. Hoofnagle

      Affiliations

    • Department of Laboratory Medicine, University of Washington, Seattle, WA, United States
  • ,
  • Peter Plomgaard

      Affiliations

    • Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Denmark
  • ,
  • Jay W. Heinecke

      Affiliations

    • Department of Medicine, University of Washington, Seattle, WA, United States
  • ,
  • Christoph J. Binder

      Affiliations

    • Department of Laboratory Medicine, Medical University of Vienna, Austria
  • ,
  • Harry Björkbacka

      Affiliations

    • Department of Clinical Sciences, Lund University, University Hospital, Malmö, Sweden
  • ,
  • Björn Dahlbäck

      Affiliations

    • Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, University Hospital, Malmö, Sweden
    • Corresponding Author InformationCorresponding author at: Wallenberg Laboratory, Entrance 46, Floor 6, University Hospital, S-20502 Malmö, Sweden. Tel.: +46 40 331501; fax: +46 40 337044.
  • ,
  • Lars B. Nielsen

      Affiliations

    • Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Denmark
    • Department of Biomedical Science, University of Copenhagen, Denmark
    • Corresponding Author InformationCorresponding author at: Department of Clinical Biochemistry, KB3011, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. Tel.: +45 3545 2304; fax: +45 3545 2524.

Received 7 March 2011; received in revised form 19 November 2011; accepted 21 November 2011. published online 28 December 2011.

Abstract 

Objective

Oxidation of LDL plays a key role in the development of atherosclerosis. HDL may, in part, protect against atherosclerosis by inhibiting LDL oxidation. Overexpression of HDL-associated apolipoprotein M (apoM) protects mice against atherosclerosis through a not yet clarified mechanism. Being a lipocalin, apoM contains a binding pocket for small lipophilic molecules. Here, we report that apoM likely serves as an antioxidant in HDL by binding oxidized phospholipids, thus enhancing the antioxidant potential of HDL.

Methods and results

HDL was isolated from wild type mice, apoM-deficient mice, and two lines of apoM-Tg mice with ∼2-fold and ∼10-fold increased plasma apoM, respectively. Increasing amounts of HDL-associated apoM were associated with an increase in the resistance of HDL to oxidation with Cu2+ or 2,2′-azobis 2-methyl-propanimidamide, dihydrochloride (AAPH) and to an increased ability of HDL to protect human LDL against oxidation. Oxidized phospholipids, but not native phospholipids, quenched the intrinsic fluorescence of recombinant human apoM and the quenching could be competed with myristic acid suggesting selective binding of oxidized phospholipid in the lipocalin-binding pocket of apoM.

Conclusions

The results suggest that apoM can bind oxidized phospholipids and that it increases the antioxidant effect of HDL. This new mechanism may explain at least part of the antiatherogenic potential of apoM.

Keywords: Apolipoprotein M, HDL, Antioxidant, Oxidized phospholipids, Atherosclerosis

 

PII: S0021-9150(11)01102-6

doi:10.1016/j.atherosclerosis.2011.11.031

Atherosclerosis
Volume 221, Issue 1 , Pages 91-97, March 2012